Blood pressure lowering effect of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist in patients with high risk hypertensio
Phase 4
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000002207
- Lead Sponsor
- Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with hypersensitive history to olmesartan medoxomil, azelnidipine, valsartan and amlodipine besilate 2. Pregnant women or women who have possibility of pregnancy 3. Patients administrated with azole antifungal drug or protease inhibitor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood lowering effect and percentage of the attainment of therapeutic goal three and six months after treatment
- Secondary Outcome Measures
Name Time Method Chenges of various biomarker six months after treatment